Net R&D expenses attained US$13.5 million , or 19.6% of sales, in the second quarter of fiscal 2021 compared to US$12 .6 million, or 22.7% of sales, in the same period last year. IFRS net loss totaled US$2.4 million , or - US$0.04 per share, in the second quarter of fiscal 2021 compared to US$9 .0 million, or - US$0 .
Posted: 2021-04-07 22:10:00
< Prev | Next > |
---|